The authors suggested that targeting lysophosphatidic acid (LPA) signaling in chronic inflammatory conditions may have rescued T cell function and promoted antiviral and antitumor immunity.
[Proceedings of the National Academy of Sciences of the United States of America]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
173925
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
